PRA, a clinical research organization (CRO), today announced the official opening of its new facility in Swansea, Wales. The new building, located on the Swansea waterfront, is a significant investment for PRA in Wales. The company is expanding its Clinical Informatics team in Swansea by establishing a new multi-lingual Help Desk, creating more positions in the Data Coordination, Clinical Programming, and Safety groups. It is planned that the expansion will create 100 new graduate-level jobs. PRA is keen to recruit high quality graduates from Swansea, Cardiff and Aberystwyth Universities and the University of South Wales, for a range of jobs from programmers to data managers.
PRA’s new Welsh home office was officially opened today by Edwina Hart AM MBE OStJ, Minister for the Economy, Science and Transport, who announced the expansion is being supported with £1.29 million business finance from the Welsh Government.
“A number of other locations were under consideration for this important expansion project so I am delighted that support from the Welsh Government helped secure it for Wales,” said Mrs. Hart. “This investment is particularly welcome as PRA is a strategically important company within the Life Sciences sector – one of our priority economic sectors with high growth potential.” She added that the expansion will create a significant number of highly-skilled jobs across a range of disciplines over the next three years and reaffirms PRA’s commitment to Wales.
Steve Powell, PRA Executive Vice President, Clinical Informatics and Late Phase Services, said, “We are delighted to officially open our expanded location in Swansea. The new site has received substantial funding from the Welsh government which will mean significant job creation and support for the local economy. As a leading CRO, we are committed to the growth of our Swansea team and to transforming clinical trials across all phases of drug development; the new building and jobs demonstrates PRA’s commitment to offering a more dynamic service to our customers, both locally and internationally.”
PRA, headquartered in North Carolina in the United States, currently employs more than 5,000 employees in over 50 global offices, with the Swansea operation currently providing 100 Clinical Informatics and administration staff who collect, analyze and interpret data from clinical trials. The planned expansion will double the size of the office and ultimately employ close to 200 people in the Swansea area.
Formerly based in Matrix Court, Swansea, PRA moved to Llys Tawe on Swansea’s SA1 development. The move supports PRA's key strategic objective of creating seamless logistics from data collection through information submission for its global customer base.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.